Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Dublin, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/fgjml9/neurostimulation) has announced the addition of the "Neurostimulation - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
This report analyzes the worldwide markets for Neurostimulation in US$ by the following Product Segments: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES).
The United States is analyzed both in terms of value (US$) and volume (units) sales.
The report profiles 30 companies including many key and niche players such as
- Aleva Neurotherapeutics SA (Switzerland)
- BioControl Medical (Israel)
- Bioness Inc. (USA)
- Boston Scientific Corp. (USA)
- EnteroMedics Inc. (USA)
- LivaNova PLC (UK)
- Medtronic, Inc. (USA)
- NeuroPace, Inc. (USA)
- NeuroSigma, Inc. (USA)
- Nevro Corp. (USA)
- SPR Therapeutics, LLC (US)
- St. Jude Medical, Inc. (USA)
- Synapse Biomedical, Inc. (USA)
Key Topics Covered:
1. MARKET OVERVIEW
2. COMPETITIVE SCENARIO
3. GROWTH DRIVERS, TRENDS, & ISSUES
4. MACRO GROWTH DRIVERS FOR NEUROSTIMULATION INDUSTRY
5. TECHNOLOGICAL ADVANCEMENTS IN NEUROSTIMULATION MARKET
6. SELECT TARGETED INDICATIONS
7. PRODUCT OVERVIEW
8. NEUROSTIMULATION DEVICE APPROVALS
9. PRODUCT INNOVATIONS/INTRODUCTIONS
10. RECENT INDUSTRY ACTIVITY
11. FOCUS ON SELECT PLAYERS
12. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 30 (including Divisions/Subsidiaries - 31)
- The United States (23)
- Europe (7)
- - Germany (2)
- - The United Kingdom (2)
- - Rest of Europe (3)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/fgjml9/neurostimulation
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices, Neurology Devices
